AAPL   240.77 (+0.11%)
FB   183.11 (-3.50%)
MSFT   136.82 (-1.17%)
AMZN   1,766.04 (-1.10%)
NVDA   196.74 (+0.37%)
MU   44.78 (-0.97%)
BABA   169.66 (-2.22%)
GE   8.96 (+1.93%)
TSLA   256.64 (+1.23%)
AMD   31.59 (-1.40%)
T   38.27 (+0.10%)
F   9.07 (+0.44%)
ACB   3.59 (-2.71%)
PRI   125.70 (+0.01%)
NFLX   267.50 (-3.79%)
BAC   31.18 (+0.52%)
GILD   66.06 (+1.30%)
DIS   132.95 (+2.07%)
AAPL   240.77 (+0.11%)
FB   183.11 (-3.50%)
MSFT   136.82 (-1.17%)
AMZN   1,766.04 (-1.10%)
NVDA   196.74 (+0.37%)
MU   44.78 (-0.97%)
BABA   169.66 (-2.22%)
GE   8.96 (+1.93%)
TSLA   256.64 (+1.23%)
AMD   31.59 (-1.40%)
T   38.27 (+0.10%)
F   9.07 (+0.44%)
ACB   3.59 (-2.71%)
PRI   125.70 (+0.01%)
NFLX   267.50 (-3.79%)
BAC   31.18 (+0.52%)
GILD   66.06 (+1.30%)
DIS   132.95 (+2.07%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 TG TherapeuticsSynthorxMacroGenicsRevance TherapeuticsAurinia Pharmaceuticals
SymbolNASDAQ:TGTXNASDAQ:THORNASDAQ:MGNXNASDAQ:RVNCNASDAQ:AUPH
Price Information
Current Price$5.54$12.65$11.03$15.16$5.08
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$13.75$25.50$32.76$34.10$16.50
% Upside from Price Target148.19% upside101.58% upside196.97% upside124.96% upside224.80% upside
Trade Information
Market Cap$523.52 million$446.29 million$556.12 million$691.05 million$475.22 million
Beta2.5N/A2.341.141.11
Average Volume1,034,52387,806321,443415,9171,531,804
Sales & Book Value
Annual Revenue$150,000.00N/A$60.12 million$3.73 million$460,000.00
Price / Sales3,502.76N/A8.97179.241,041.29
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.29 per share$6.72 per share$5.75 per share$3.94 per share$1.32 per share
Price / Book19.10N/A1.923.853.85
Profitability
Net Income$-173,480,000.00$-56,610,000.00$-171,450,000.00$-142,570,000.00$-64,120,000.00
EPSN/A($6.59)($4.19)($3.94)($0.76)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-99,488.13%N/A-273.47%-3,745.97%-13,231.97%
Return on Equity (ROE)-496.99%N/A-54.52%-79.28%-50.08%
Return on Assets (ROA)-150.99%N/A-41.85%-54.14%-40.69%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.77%N/A0.08%0.15%N/A
Current Ratio1.69%22.77%5.81%5.59%18.98%
Quick Ratio1.69%22.77%5.81%5.59%18.98%
Ownership Information
Institutional Ownership Percentage52.99%65.62%95.88%98.75%31.12%
Insider Ownership Percentage14.20%53.20%7.88%5.20%N/A
Miscellaneous
Employees1053936417039
Shares Outstanding94.84 million32.27 million48.89 million44.10 million94.29 million
Next Earnings Date11/8/2019 (Estimated)11/7/2019 (Estimated)11/6/2019 (Estimated)11/7/2019 (Estimated)11/14/2019 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 TG TherapeuticsSynthorxMacroGenicsRevance TherapeuticsAurinia Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel